Both in Surgical Instruments
Stryker vs DexCom
Over the past year SYK returned −25.6% and DXCM returned +30.4%; their daily moves had a correlation of 0.33.
SYK −25.6% DXCM +30.4%Growth of $1, one year, split-adjusted
| Metric | SYK | DXCM |
|---|---|---|
| Price | $275.31 | $86.68 |
| Market cap | $105.60B | $32.71B |
| Today | +1.08% | +0.07% |
| 1 month | −14.5% | −2.9% |
| 6 months | −15.9% | +39.2% |
| Year to date | −21.7% | +30.6% |
| 1 year | −25.3% | +26.9% |
| Revenue growth (YoY) | +9.4% | +13.1% |
| Gross margin | 68.3% | 63.4% |
| Net margin | 19.4% | 19.0% |
| P/E (TTM) | 28.3× | 32.7× |
| Price / sales | 4.1× | 6.6× |
| Net cash | -$11.47B | $704.2M |
| Dividend yield | 1.28% | — |
| Volatility (60d) | 38.8% | 39.6% |
| Short % of float | 2.2% | 4.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).